1 |
Basset P, Bellocq JP, Wolf C, et al (1990). A novel Metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature, 348, 699-704.
DOI
|
2 |
Basset P, Wolf C, Chambon P (1993). Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review. Breast Cancer Res Treat, 24, 185-93.
DOI
|
3 |
Bono AV, Celato N, Cova V, et al (2002). Microvessel density in prostate carcinoma. Prostate Cancer Prostatic Dis, 5, 123-7.
DOI
|
4 |
Choy M, Rafii S (2001). Role of angiogenesis in the progression and treatment of prostate cancer. Cancer Invest, 19, 181-91.
DOI
|
5 |
Concato J, Jain D, Uchio E, et al (2009). Molecular markers and death from prostate cancer. Ann Intern Med, 150, 595-603.
DOI
|
6 |
Condon MS (2005). The role of the stromal microenvironment in prostate cancer. Sem Cancer Biol, 15, 132-7.
DOI
|
7 |
Deryugina EI, Quigley JP (2015). Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasissustaining neovasculature. Matrix Biol, (in press).
|
8 |
Erbersdobler A, Isbarn H, Dix K (2010). Prognostic value of microvessel density in prostate cancer: a tissue microarray study. World J Urol, 28, 687-92.
DOI
|
9 |
Escaff S, Fernandez JM, Gonzalez LO, et al (2010). Study of matrix metalloproteinases and their inhibitors in prostate cancer. Br J Cancer, 102, 922-9.
DOI
|
10 |
Fidler IJ, Ellis LM, (1994). The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell, 79, 185-8.
DOI
|
11 |
Folkman J (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med, 285, 1182-6.
DOI
|
12 |
Folkman J (1990). What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst, 82, 4-6.
DOI
|
13 |
Folkman J (1992). The role of angiogenesis in tumor growth. Semin Cancer Biol, 3, 65-71.
|
14 |
Folkman J, Watson K, Ingber D, et al (1989). Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature, 339, 58-61.
DOI
|
15 |
Gimbrone MA Jr, Leapman SB, Cotran RS, et al (1972). Tumor dormancy in vivo by prevention of neovascularization. J Exp Med, 136, 261-76.
DOI
|
16 |
Globocan (2012). Prostate cancer: estimated incidence, mortality and prevalence worldwide in 2012 [Online]. Available:http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
|
17 |
Iakovlev VV, Gabril M, Dubinski W, et al (2012). Microvascular density as an independent predictor of clinical outcome in renal cell carcinoma: an automated image analysis study. Laboratory Investigation, 92, 46-56.
DOI
|
18 |
Khuhaprema T, Srivatanakul P, Attasara P, et al (2013). Cancer in Thailand Volume VII 2007-2009. National cancer institute, 7, 12.
|
19 |
Kaygusuz G, Tulunay O, Baltaci S, et al (2007). Microvessel density and regulators of angiogenesis in malignant and nonmalignant prostate tissue. Int Urol Nephrol, 39, 841-50.
DOI
|
20 |
Kessenbrock K, Plaks V, Werb (2010). Matrix Metalloproteinases: Regulators of the Tumor Microenvironment. Cell, 141, 52-67.
DOI
|
21 |
Lin CW, Yang SF, Chuang CY, et al (2014). Association of matrix metalloproteinase-11 polymorphisms with susceptibility and clinicopathologic characteristics for oral squamous cell carcinoma. Head Neck, DOI: 10.1002/hed.23771.
|
22 |
Manes S, Mira E, Barbacid MD, et al (1997). Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3. J Biol Chem, 272, 25706-12.
DOI
|
23 |
Min KW, Kim DH, Do SI, et al (2013). Diagnostic and prognostic relevance of MMP-11 expression in the stromal fibroblastlike cells adjacent to invasive ductal carcinoma of the breast. Ann Surg Oncol, 20, 433-42.
DOI
|
24 |
Montironi R, Diamanti L, Thompson D, et al (1996). Analysis of the capillary architecture in the precursors of prostate cancer: recent findings and new concepts. Eur Urol, 30, 191-200.
|
25 |
Murphy G, Segain JP, O'Shea M, et al (1993). The 28-kDa N-terminal domain of mouse stromelysin-3- has the general properties of a weak metalloproteinase. J Biol Chem, 268, 15435-41.
|
26 |
Nagase H, Woesser JF Jr (1999). Matrix metalloproteinases. J Bio Chem, 274, 21491-4.
DOI
|
27 |
Nicholson B, Theodorescu D (2004). Angiogenesis and prostate cancer tumor growth. J Cellular Biochemistry, 91, 125-50.
DOI
ScienceOn
|
28 |
Roscilli G, Cappelletti M, Vitis CD, et al (2014). Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients. J Translational Med, 12, 54.
DOI
|
29 |
Nonsrijun N, Mitchai J, Brown K, et al (2013). Overexpression of matrix metalloproteinase 11 in Thai prostatic adenocarcinoma associated with poor survival outcome. Asian Pac J Cancer Prev, 14, 3331-5.
DOI
|
30 |
Pei D, Majmudar G, Weiss SJ, (1994). Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3. J Biol Chem, 269, 25849-55.
|
31 |
Rundhaug JE (2005). Matrix metalloproteinases, angiogenesis, and cancer. J Cell Mol Med, 9, 267-85.
DOI
|
32 |
Sinha AA, Quast BJ, Reddy PK, et al (2004). Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer. Experimental and Molecular Pathology, 77, 153-9.
DOI
|
33 |
Taille Adl, Katz AE, Bagiella E, et al (2000). Microvessel density as a predictor of PSA recurrence after radical prostatectomy a comparison of CD34 and CD31. Am J Clin Pathol, 113, 555-62.
DOI
|
34 |
Tang Y, Nakada MT, Kesavan P, et al (2005). Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases. Cancer Res, 65, 3193-9.
|
35 |
Tuamsuk P, Nonsrijun N, Pachirat K, et al (2011). Prostate cancer in Srinagarind Hospital. Srinagarind Med J, 26, 373-6.
|
36 |
van Moorselaar RJ, Voest EE (2002). Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches. Molecular and Cellular Endocrinology, 197, 239-50.
DOI
|
37 |
Zhao ZS, Chu YQ, Ye ZY, et al (2010). Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance. Hum Pathol, 41, 686-96.
DOI
ScienceOn
|
38 |
Weidner N, Carroll PR, Flax J, et al (1993). Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol, 143, 401-9,
|
39 |
Yodavudh S, Tangjitgamol S, Puangsa-art S (2008). Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer. J Med Assoc Thai, 91, 723-32.
|